Review



bms493  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Tocris bms493
    Bms493, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 111 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms493/pm41402467-392-19-22?v=Tocris
    Average 94 stars, based on 111 article reviews
    bms493 - by Bioz Stars, 2026-08
    94/100 stars

    Images



    Similar Products

    94
    MedChemExpress bms493
    Bms493, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms493/pmc13134484-1347-0-2?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    bms493 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress inverse pan retinoic acid receptor rar agonist bms493
    Inverse Pan Retinoic Acid Receptor Rar Agonist Bms493, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms493/pm41896269-172-57-64?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    inverse pan retinoic acid receptor rar agonist bms493 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress bms 493
    LAMB3–ITGA6 axis in keratinization model of human oral keratinocytes. (A) Sample-to-sample Pearson correlation heat map of RNA-seq profiles (n = 3 per condition) derived from HOK cells exposed to vehicle (0.1% DMSO; NC), 10 μM RA, or 500 nM <t>BMS-493.</t> (B) Z-score-normalised expression heat map of differentially expressed genes (DEGs) across NC, RA and BMS-493 treatments. (C) GO enrichment analysis of DEGs (RA vs. BMS-493) highlighting upregulation of skin/epidermal development, keratinocyte differentiation and cell adhesion. (D) Immunoblots of HOK cells treated for 7 days with all-trans retinoic acid (RA; 0, 1, 10 µM) or the pan-RAR antagonist BMS-493 (0, 100, 500 nM) showing dose-dependent modulation of LAMB3, ITGA6, IVL, KRT8, FLG, KRT18, LOR and GAPDH.
    Bms 493, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms493/pmc13057497-32-10-12?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    bms 493 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress cells
    LAMB3–ITGA6 axis in keratinization model of human oral keratinocytes. (A) Sample-to-sample Pearson correlation heat map of RNA-seq profiles (n = 3 per condition) derived from HOK cells exposed to vehicle (0.1% DMSO; NC), 10 μM RA, or 500 nM <t>BMS-493.</t> (B) Z-score-normalised expression heat map of differentially expressed genes (DEGs) across NC, RA and BMS-493 treatments. (C) GO enrichment analysis of DEGs (RA vs. BMS-493) highlighting upregulation of skin/epidermal development, keratinocyte differentiation and cell adhesion. (D) Immunoblots of HOK cells treated for 7 days with all-trans retinoic acid (RA; 0, 1, 10 µM) or the pan-RAR antagonist BMS-493 (0, 100, 500 nM) showing dose-dependent modulation of LAMB3, ITGA6, IVL, KRT8, FLG, KRT18, LOR and GAPDH.
    Cells, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms493/pmc13057497-32-3-12?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    cells - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    86
    Fisher Scientific pan rar antagonist bms493
    (A) Vitamin A-derived retinol is metabolized to RA, which activates retinoic acid receptors (RARs). RARs bind target gene promoters to drive RA-dependent transcription. (B) HT-29 cells (human intestinal epithelial cells) were treated with the RAR antagonist <t>BMS493</t> or the RAR agonist Ch55 and simultaneously stimulated overnight with RA and IL-22. REG3G transcripts were quantified by qPCR. Each data point represents an independent experimental replicate (n=6 per group). (C) HCT-116, a transfection-competent human intestinal epithelial cell line expressing RARA and RARG , was treated for 24 hours with an siRNA targeting either gene and then stimulated overnight with retinol and IL-22. REG3G transcripts were quantified by qPCR. Each data point represents an independent experimental replicate (n=4 per group). (D) IEC-specific disruption of RAR signaling using a dominant-negative RAR (dnRAR) knock-in allele. dnRAR mice harbor a loxP -flanked STOP cassette upstream of a dominant-negative RAR open reading frame. The dnRAR is derived from a mutant human RARα (RAR403) lacking the ligand-dependent transactivation domain and functions as a pan-RAR inhibitor. Crossing dnRAR mice with Villin-Cre transgenic mice excises the STOP cassette in IECs, resulting in IEC-selective expression of dnRAR and inhibition of RAR signaling. (E) qPCR analysis of Reg3g expression in small intestines of conventional dnRAR fl/fl (n=12) and dnRAR IEC (n=17) mice from five litters, and germ-free wild-type mice (n=21). (F) Immunofluorescence microscopy of REG3G in small intestines of dnRAR fl/fl and dnRAR IEC mice. Sections were stained for REG3G and counterstained with DAPI. Scale bar, 100 μ m. Images are representative of at least three fields per sample and two independent experiments (three littermates per group). (G) Mean fluorescence intensities of at least 150 villi from the images represented in (F) were quantified across at least two mice of each genotype. RAR, retinoic acid receptor; RA, retinoic acid; IEC, intestinal epithelial cell; REG3G, regenerating islet-derived protein 3γ; siRNA, small interfering RNA; dnRAR, dominant negative retinoic acid receptor; Conv, conventional; GF, germ-free. Means ± SEM are plotted; *p < 0.05; **p < 0.01; ***p<0.001; ns, not significant by Mann-Whitney test. See also .
    Pan Rar Antagonist Bms493, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms493/bio_rxiv__64898__2026__03__08__710399-208-12-15?v=Fisher+Scientific
    Average 86 stars, based on 1 article reviews
    pan rar antagonist bms493 - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    94
    Tocris bms493
    (A) Vitamin A-derived retinol is metabolized to RA, which activates retinoic acid receptors (RARs). RARs bind target gene promoters to drive RA-dependent transcription. (B) HT-29 cells (human intestinal epithelial cells) were treated with the RAR antagonist <t>BMS493</t> or the RAR agonist Ch55 and simultaneously stimulated overnight with RA and IL-22. REG3G transcripts were quantified by qPCR. Each data point represents an independent experimental replicate (n=6 per group). (C) HCT-116, a transfection-competent human intestinal epithelial cell line expressing RARA and RARG , was treated for 24 hours with an siRNA targeting either gene and then stimulated overnight with retinol and IL-22. REG3G transcripts were quantified by qPCR. Each data point represents an independent experimental replicate (n=4 per group). (D) IEC-specific disruption of RAR signaling using a dominant-negative RAR (dnRAR) knock-in allele. dnRAR mice harbor a loxP -flanked STOP cassette upstream of a dominant-negative RAR open reading frame. The dnRAR is derived from a mutant human RARα (RAR403) lacking the ligand-dependent transactivation domain and functions as a pan-RAR inhibitor. Crossing dnRAR mice with Villin-Cre transgenic mice excises the STOP cassette in IECs, resulting in IEC-selective expression of dnRAR and inhibition of RAR signaling. (E) qPCR analysis of Reg3g expression in small intestines of conventional dnRAR fl/fl (n=12) and dnRAR IEC (n=17) mice from five litters, and germ-free wild-type mice (n=21). (F) Immunofluorescence microscopy of REG3G in small intestines of dnRAR fl/fl and dnRAR IEC mice. Sections were stained for REG3G and counterstained with DAPI. Scale bar, 100 μ m. Images are representative of at least three fields per sample and two independent experiments (three littermates per group). (G) Mean fluorescence intensities of at least 150 villi from the images represented in (F) were quantified across at least two mice of each genotype. RAR, retinoic acid receptor; RA, retinoic acid; IEC, intestinal epithelial cell; REG3G, regenerating islet-derived protein 3γ; siRNA, small interfering RNA; dnRAR, dominant negative retinoic acid receptor; Conv, conventional; GF, germ-free. Means ± SEM are plotted; *p < 0.05; **p < 0.01; ***p<0.001; ns, not significant by Mann-Whitney test. See also .
    Bms493, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms493/pm41402467-392-19-22?v=Tocris
    Average 94 stars, based on 1 article reviews
    bms493 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    Image Search Results


    LAMB3–ITGA6 axis in keratinization model of human oral keratinocytes. (A) Sample-to-sample Pearson correlation heat map of RNA-seq profiles (n = 3 per condition) derived from HOK cells exposed to vehicle (0.1% DMSO; NC), 10 μM RA, or 500 nM BMS-493. (B) Z-score-normalised expression heat map of differentially expressed genes (DEGs) across NC, RA and BMS-493 treatments. (C) GO enrichment analysis of DEGs (RA vs. BMS-493) highlighting upregulation of skin/epidermal development, keratinocyte differentiation and cell adhesion. (D) Immunoblots of HOK cells treated for 7 days with all-trans retinoic acid (RA; 0, 1, 10 µM) or the pan-RAR antagonist BMS-493 (0, 100, 500 nM) showing dose-dependent modulation of LAMB3, ITGA6, IVL, KRT8, FLG, KRT18, LOR and GAPDH.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: The LAMB3–ITGA6 axis orchestrates epithelial repair in periodontitis via hemidesmosomal regulation and keratinization modulation

    doi: 10.3389/fcell.2026.1764896

    Figure Lengend Snippet: LAMB3–ITGA6 axis in keratinization model of human oral keratinocytes. (A) Sample-to-sample Pearson correlation heat map of RNA-seq profiles (n = 3 per condition) derived from HOK cells exposed to vehicle (0.1% DMSO; NC), 10 μM RA, or 500 nM BMS-493. (B) Z-score-normalised expression heat map of differentially expressed genes (DEGs) across NC, RA and BMS-493 treatments. (C) GO enrichment analysis of DEGs (RA vs. BMS-493) highlighting upregulation of skin/epidermal development, keratinocyte differentiation and cell adhesion. (D) Immunoblots of HOK cells treated for 7 days with all-trans retinoic acid (RA; 0, 1, 10 µM) or the pan-RAR antagonist BMS-493 (0, 100, 500 nM) showing dose-dependent modulation of LAMB3, ITGA6, IVL, KRT8, FLG, KRT18, LOR and GAPDH.

    Article Snippet: For keratinization promotion: cells received 0, 100, or 500 nM BMS 493 (MCE, HY-108529), a pan-retinoic acid receptor antagonist ( ; ).

    Techniques: RNA Sequencing, Derivative Assay, Expressing, Western Blot

    (A) Vitamin A-derived retinol is metabolized to RA, which activates retinoic acid receptors (RARs). RARs bind target gene promoters to drive RA-dependent transcription. (B) HT-29 cells (human intestinal epithelial cells) were treated with the RAR antagonist BMS493 or the RAR agonist Ch55 and simultaneously stimulated overnight with RA and IL-22. REG3G transcripts were quantified by qPCR. Each data point represents an independent experimental replicate (n=6 per group). (C) HCT-116, a transfection-competent human intestinal epithelial cell line expressing RARA and RARG , was treated for 24 hours with an siRNA targeting either gene and then stimulated overnight with retinol and IL-22. REG3G transcripts were quantified by qPCR. Each data point represents an independent experimental replicate (n=4 per group). (D) IEC-specific disruption of RAR signaling using a dominant-negative RAR (dnRAR) knock-in allele. dnRAR mice harbor a loxP -flanked STOP cassette upstream of a dominant-negative RAR open reading frame. The dnRAR is derived from a mutant human RARα (RAR403) lacking the ligand-dependent transactivation domain and functions as a pan-RAR inhibitor. Crossing dnRAR mice with Villin-Cre transgenic mice excises the STOP cassette in IECs, resulting in IEC-selective expression of dnRAR and inhibition of RAR signaling. (E) qPCR analysis of Reg3g expression in small intestines of conventional dnRAR fl/fl (n=12) and dnRAR IEC (n=17) mice from five litters, and germ-free wild-type mice (n=21). (F) Immunofluorescence microscopy of REG3G in small intestines of dnRAR fl/fl and dnRAR IEC mice. Sections were stained for REG3G and counterstained with DAPI. Scale bar, 100 μ m. Images are representative of at least three fields per sample and two independent experiments (three littermates per group). (G) Mean fluorescence intensities of at least 150 villi from the images represented in (F) were quantified across at least two mice of each genotype. RAR, retinoic acid receptor; RA, retinoic acid; IEC, intestinal epithelial cell; REG3G, regenerating islet-derived protein 3γ; siRNA, small interfering RNA; dnRAR, dominant negative retinoic acid receptor; Conv, conventional; GF, germ-free. Means ± SEM are plotted; *p < 0.05; **p < 0.01; ***p<0.001; ns, not significant by Mann-Whitney test. See also .

    Journal: bioRxiv

    Article Title: Epithelial sensing of vitamin A shapes intestinal antimicrobial defense

    doi: 10.64898/2026.03.08.710399

    Figure Lengend Snippet: (A) Vitamin A-derived retinol is metabolized to RA, which activates retinoic acid receptors (RARs). RARs bind target gene promoters to drive RA-dependent transcription. (B) HT-29 cells (human intestinal epithelial cells) were treated with the RAR antagonist BMS493 or the RAR agonist Ch55 and simultaneously stimulated overnight with RA and IL-22. REG3G transcripts were quantified by qPCR. Each data point represents an independent experimental replicate (n=6 per group). (C) HCT-116, a transfection-competent human intestinal epithelial cell line expressing RARA and RARG , was treated for 24 hours with an siRNA targeting either gene and then stimulated overnight with retinol and IL-22. REG3G transcripts were quantified by qPCR. Each data point represents an independent experimental replicate (n=4 per group). (D) IEC-specific disruption of RAR signaling using a dominant-negative RAR (dnRAR) knock-in allele. dnRAR mice harbor a loxP -flanked STOP cassette upstream of a dominant-negative RAR open reading frame. The dnRAR is derived from a mutant human RARα (RAR403) lacking the ligand-dependent transactivation domain and functions as a pan-RAR inhibitor. Crossing dnRAR mice with Villin-Cre transgenic mice excises the STOP cassette in IECs, resulting in IEC-selective expression of dnRAR and inhibition of RAR signaling. (E) qPCR analysis of Reg3g expression in small intestines of conventional dnRAR fl/fl (n=12) and dnRAR IEC (n=17) mice from five litters, and germ-free wild-type mice (n=21). (F) Immunofluorescence microscopy of REG3G in small intestines of dnRAR fl/fl and dnRAR IEC mice. Sections were stained for REG3G and counterstained with DAPI. Scale bar, 100 μ m. Images are representative of at least three fields per sample and two independent experiments (three littermates per group). (G) Mean fluorescence intensities of at least 150 villi from the images represented in (F) were quantified across at least two mice of each genotype. RAR, retinoic acid receptor; RA, retinoic acid; IEC, intestinal epithelial cell; REG3G, regenerating islet-derived protein 3γ; siRNA, small interfering RNA; dnRAR, dominant negative retinoic acid receptor; Conv, conventional; GF, germ-free. Means ± SEM are plotted; *p < 0.05; **p < 0.01; ***p<0.001; ns, not significant by Mann-Whitney test. See also .

    Article Snippet: Pharmacologic modulation of retinoic acid receptor (RAR) activity was performed using the pan-RAR antagonist BMS493 (Fisher Scientific) or the pan-RAR agonist Ch55 (Tocris).

    Techniques: Derivative Assay, Transfection, Expressing, Disruption, Dominant Negative Mutation, Knock-In, Mutagenesis, Transgenic Assay, Inhibition, Immunofluorescence, Microscopy, Staining, Fluorescence, Small Interfering RNA, MANN-WHITNEY